Dr. Kipper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 800-926-8273Fax+1 888-539-8781
Education & Training
University of California (San Diego) Medical CenterResidency, Nuclear Medicine, 1979 - 1981- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1973 - 1975
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1971 - 1973
David Geffen School of Medicine at UCLAClass of 1971
Certifications & Licensure
CA State Medical License 1972 - 2025
MI State Medical License 2017 - 2018
AZ State Medical License 2009 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
Publications & Presentations
PubMed
- 2 citationsUnderstanding and Improving 18F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate Cancer.Benjamin H Lowentritt, Michael S Kipper
Prostate Cancer. 2020-04-26 - 2 citationsSteps in moving molecular imaging to the clinic.Michael S. Kipper
Journal of Nuclear Medicine. 2008-06-01 - 1 citationsPositron emission tomography scan findings of autoimmune lymphoproliferative syndrome.Marie Tartar, Michael S. Kipper
Molecular Imaging and Biology. 2004-05-01
Press Mentions
Blue Earth Diagnostics Announces Axumin® (Fluciclovine F 18) LOCATE Study Presentation at Upcoming ASCO 2019 Genitourinary Cancers Symposium on Impact on Clinical Management of Recurrent Prostate CancerFebruary 7th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
